Skip to main content
Fig. 9 | Molecular Cancer

Fig. 9

From: Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development

Fig. 9

The immune landscape of CHOL. a The immune landscape of CHOL. The location of individual patients in the immune landscape with the color corresponding to the immune subtype identified above, which represents the overall characteristics of the TIME. b Correlation between PCA1/2 and immune modules. c-d Patients separated by the immune landscape based on their location (c). Separated patients were associated with different prognoses (d). e Further stratification of IS1 and IS2 based on their location on the immune landscape. f Different groups in IS1 associated with different prognoses. g Different groups in IS2 associated with different prognoses

Back to article page

Molecular Cancer

ISSN: 1476-4598